检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:叶国麟[1,2] 杨劼[1,2] 古卫权[1,2] 潘瑞琳[1,2] 廖富毅[1,2] 叶俊[1,2] 朱乐伟[1,2] 王飞[1,2] 杨胜利[1,2]
机构地区:[1]中山大学附属佛山医院 [2]广东省佛山市第一人民医院胸外科,广东佛山528000
出 处:《河北医学》2013年第6期832-834,共3页Hebei Medicine
摘 要:目的:探讨"三阴性"乳腺癌Ki-67表达对新辅助化疗疗效的预测价值,有助于乳腺癌治疗的选择及预后。方法:对74例分别实施TEC及CEF方案新辅助化疗的"三阴性"乳腺癌病例进行回顾性分析,应用免疫组化法检测化疗前后Ki-67表达,分析Ki-67表达与疗效关系。结果:Ki-67高表达患者接受CET新辅助化疗化疗PCR率更高。结论:Ki-67的高表达可以作为"三阴性"乳腺癌CET方案化疗疗效预测指标。Objective: To explore the influence of Ki-67 expression in triple-negative breast cancer to the predictive value of neo-adjuvant chemotherapy, and to assist selecting of treatment methods and progno- sis of breast cancer. Methods: Retrospective analysis was carried out in 74 patients with triple- negative breast cancer who underwent TEC and CEF neo-adjuvant chemotherapy regimens, and the expression of Ki- 67 was investigated by immunohistochemistry. In addition, the relation between Ki-67 expression and treat- ment effect was also analyzed. Result: PCR rate was detected high in patients with high Ki-67. expression. Conclusions:High Ki-67 expression can be regarded as the predictive index of CEF chemotherapy regimen in triple-negative breast cancer.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.249